Jan Lewerenz
Jan Lewerenz publishes mostly in Neurology, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Autoimmune Neurological Disorders and Treatments, Genetic Neurodegenerative Diseases and Peripheral Neuropathies and Disorders.
- World rank
- #196,552 of 7,710,434 ranked researchers
- Rank in Germany
- #9,988 of 364,343
- Works
- 181
- Citations
- 9.4k
- Citations per work
- 51.7
What does Jan Lewerenz research?
Jan Lewerenz's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (16%), Neuroscience (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7139.5%
- Medicine7139.5%
- Everything else6234.2%
- Life Sciences4826.3%
- Biochemistry, Genetics and Molecular Biology2815.5%
- Neuroscience2010.8%
- 1Neurology28% of their works
- 2Molecular Biology11% of their works
- 3Cellular and Molecular Neuroscience11% of their works
- 4Pathology and Forensic Medicine7% of their works
- 5Rheumatology4% of their works
- 6Biochemistry4% of their works
Research topics
- Autoimmune Neurological Disorders and Treatments
- Genetic Neurodegenerative Diseases
- Peripheral Neuropathies and Disorders
- Multiple Sclerosis Research Studies
- Neuroscience and Neuropharmacology Research
- Amino Acid Enzymes and Metabolism
- Immunodeficiency and Autoimmune Disorders
- Mitochondrial Function and Pathology
Which keywords describe Jan Lewerenz's research?
The keywords of their largest research topics: Neurological Disorders, Cognitive Impairment, Diagnostic Criteria, Anti-NMDA Receptor Encephalitis, Paraneoplastic Syndromes, Mitochondrial Dysfunction, Huntington's Disease and Protein Aggregation.
- Reactive Oxygen Species
- Primary Immunodeficiency
- D-Serine
- Synaptic Plasticity
- Neuromyelitis Optica
- Guillain-Barré Syndrome
- Protein Aggregation
- Mitochondrial Dysfunction
- Anti-NMDA Receptor Encephalitis
- Cognitive Impairment
- Neurological Disorders
- Diagnostic Criteria
- Paraneoplastic Syndromes
- Huntington's Disease
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Multiple Sclerosis
- Neurotransmission
- Amino Acid Transporters
- Genetic Mutations
- Mitochondria
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Neurological Disorders1073 topics
- Cognitive Impairment872 topics
- Diagnostic Criteria872 topics
- Anti-NMDA Receptor Encephalitis651 topic
- Paraneoplastic Syndromes651 topic
- Mitochondrial Dysfunction412 topics
- Huntington's Disease311 topic
- Protein Aggregation311 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy261 topic
- Guillain-Barré Syndrome261 topic
- Multiple Sclerosis221 topic
- Neuromyelitis Optica221 topic
- Neurotransmission161 topic
- Synaptic Plasticity161 topic
- Amino Acid Transporters121 topic
- D-Serine121 topic
- Genetic Mutations111 topic
- Primary Immunodeficiency111 topic
- Mitochondria101 topic
- Reactive Oxygen Species101 topic
Where does Jan Lewerenz work?
Jan Lewerenz's main affiliation in the publication record is Universität Ulm, Germany.
How many publications and citations does Jan Lewerenz have?
OpenAlex counts 181 works and 9,359 citations for Jan Lewerenz, an h-index of 44, ranking #196,552 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jan Lewerenz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.